Sale!

Oncopro Pan Cancer Monitor Test

6,080 د.إ

-10%

The Oncopro Pan Cancer Monitor Test, available at DNA Labs UAE for a cost of 6080 AED, represents a cutting-edge advancement in the realm of cancer diagnostics and monitoring. This comprehensive test is designed to detect and monitor various types of cancer through a minimally invasive approach, using a simple blood sample to analyze circulating tumor DNA (ctDNA). By identifying specific genetic mutations and alterations associated with cancer, the Oncopro Pan Cancer Monitor Test offers a personalized and dynamic insight into the patient’s disease status, helping to guide treatment decisions, monitor response to therapy, and detect potential relapse at an early stage. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a pivotal tool in the precision medicine approach to cancer care, providing crucial information for both patients and healthcare providers in the management of the disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOPRO PAN CANCER MONITOR Test

At DNA Labs UAE, we offer the ONCOPRO PAN CANCER MONITOR Test, a diagnostic test used to monitor cancer patients for the presence of circulating tumor DNA (ctDNA) in their blood.

Test Cost: AED 6080.0

The ONCOPRO PAN CANCER MONITOR Test is available for a cost of AED 6080.0.

Test Components

  • Sample Condition: 8 mL whole blood in 1 Lavender Top (EDTA) tube in sample collection kit available from LPL. Add the preservative supplied in the kit to the EDTA tube using a syringe & needle. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE.
  • Report Delivery: 21 Working days
  • Method: Extraction, Staining
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information

Duly filled Oncopro Pan Cancer Monitor Clinical Information Form (Form 31) is mandatory before taking the test.

Test Details

The ONCOPRO PAN CANCER MONITOR Test is designed to detect ctDNA from a variety of cancer types, including breast, lung, colorectal, and prostate cancer. It uses advanced sequencing technology to detect ctDNA in a patient’s blood sample. This ctDNA is released into the bloodstream by cancer cells as they grow and divide.

The test is typically performed on a regular basis, such as every three to six months, to monitor changes in ctDNA levels over time. By tracking these changes, doctors can adjust treatment plans and make more informed decisions about a patient’s care.

Overall, the ONCOPRO PAN CANCER MONITOR Test is a valuable tool for cancer patients and their doctors, providing important information about the progression of the disease and the effectiveness of treatment.

Test Name ONCOPRO PAN CANCER MONITOR Test
Components
Price 6080.0 AED
Sample Condition 8 mL whole bloodin 1 Lavender Top (EDTA) tube in sample collection kit available from LPL. Add the preservative supplied in the kit to the EDTA tube using a syringe & needle. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Duly filled Oncopro Pan Cancer Monitor Clinical Information Form (Form 31) is mandatory.
Report Delivery 21 Working days
Method Extraction, Staining
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Oncopro Pan Cancer Monitor Clinical Information Form (Form 31) is mandatory.
Test Details

The ONCOPRO PAN CANCER MONITOR test is a diagnostic test used to monitor cancer patients for the presence of circulating tumor DNA (ctDNA) in their blood. This test is designed to detect ctDNA from a variety of cancer types, including breast, lung, colorectal, and prostate cancer.

The ONCOPRO PAN CANCER MONITOR test uses advanced sequencing technology to detect ctDNA in a patient’s blood sample. This ctDNA is released into the bloodstream by cancer cells as they grow and divide, and can be used to monitor the progression of the disease and the effectiveness of treatment.

The test is typically performed on a regular basis, such as every three to six months, to monitor changes in ctDNA levels over time. By tracking these changes, doctors can adjust treatment plans and make more informed decisions about a patient’s care.

Overall, the ONCOPRO PAN CANCER MONITOR test is a valuable tool for cancer patients and their doctors, providing important information about the progression of the disease and the effectiveness of treatment.